Literature DB >> 17192554

Immunomodulatory properties of substance P: the gastrointestinal system as a model.

Hon Wai Koon1, Charalabos Pothoulakis.   

Abstract

Communication between nerves and immune and inflammatory cells of the small and large intestine plays a major role in the modulation of several intestinal functions, including intestinal motility, ion transport, and mucosal permeability. Neuroimmune interactions at intestinal sites have been associated with the pathophysiology of infectious and enterotoxin-mediated diarrhea and intestinal inflammation, including inflammatory bowel disease (IBD). During the past 20 years the neuropeptide substance P (SP) has been identified as an important mediator in the development and progress of intestinal inflammation by binding to its high-affinity neurokinin-1 receptor (NK-1R). This peptide, released from enteric nerves, sensory neurons, and inflammatory cells of the lamina propria during intestinal inflammation, participates in gut inflammation by interacting, directly or indirectly, with NK-1R expressed on nerves, epithelial cells, and immune and inflammatory cells, such as mast cells, macrophages, and T cells. SP-dependent activation of these cells leads to the release of cytokines and chemokines as well as other neuropeptides that modulate diarrhea, inflammation, and motility associated with the pathophysiology of several intestinal disease states. The recent development of specific nonpeptide NK-1R antagonists and NK-1R-deficient mice helped us understand the functional importance of the SP-NK-1R system in mediating intestinal neuroimmune interactions and to identify the particular cells and signaling pathways involved in this response. This review summarizes our understanding on the immunomodulatory properties of SP and its receptor in the intestinal tract with particular focus on their involvement in intestinal physiology as well as in the pathophysiology of several intestinal disease states at the in vivo and cell signaling level.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17192554     DOI: 10.1196/annals.1366.024

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  34 in total

1.  Association of TNFSF15 polymorphism with irritable bowel syndrome.

Authors:  Marco Zucchelli; Michael Camilleri; Anna Nixon Andreasson; Francesca Bresso; Aldona Dlugosz; Jonas Halfvarson; Leif Törkvist; Peter T Schmidt; Pontus Karling; Bodil Ohlsson; Richard H Duerr; Magnus Simren; Greger Lindberg; Lars Agreus; Paula Carlson; Alan R Zinsmeister; Mauro D'Amato
Journal:  Gut       Date:  2011-06-02       Impact factor: 23.059

2.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

3.  Role of substance P in the regulation of glucose metabolism via insulin signaling-associated pathways.

Authors:  Iordanes Karagiannides; Kyriaki Bakirtzi; Efi Kokkotou; Dimitris Stavrakis; Kara Gross Margolis; Thomas Thomou; Nino Giorgadze; James L Kirkland; Charalabos Pothoulakis
Journal:  Endocrinology       Date:  2011-10-18       Impact factor: 4.736

4.  Modulation of lymphatic muscle contractility by the neuropeptide substance P.

Authors:  Michael J Davis; Megan M Lane; Ann M Davis; David Durtschi; David C Zawieja; Mariappan Muthuchamy; Anatoliy A Gashev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-06       Impact factor: 4.733

Review 5.  Tachykinin peptide, substance P, and its receptor NK-1R play an important role in alimentary tract mucosal inflammation during cytotoxic therapy.

Authors:  P S Satheeshkumar; Minu P Mohan
Journal:  Dig Dis Sci       Date:  2014-07-01       Impact factor: 3.199

6.  Immunostimulatory effects of mesenchymal stem cell-derived neurons: implications for stem cell therapy in allogeneic transplantations.

Authors:  Marianne D Castillo; Katarzyna A Trzaska; Steven J Greco; Nicholas M Ponzio; Pranela Rameshwar
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

7.  Substance P induces CCN1 expression via histone deacetylase activity in human colonic epithelial cells.

Authors:  Hon Wai Koon; David Q Shih; Tressia C Hing; Jeremy Chen; Samantha Ho; Dezheng Zhao; Stephan R Targan; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2011-09-23       Impact factor: 4.307

8.  Role of neurokinin 1 receptors in dextran sulfate-induced colitis: studies with gene-deleted mice and the selective receptor antagonist netupitant.

Authors:  István Szitter; Erika Pintér; Anikó Perkecz; Agnes Kemény; József Kun; László Kereskai; Claudio Pietra; John P Quinn; Andreas Zimmer; Alexandra Berger; Christopher J Paige; Zsuzsanna Helyes
Journal:  Inflamm Res       Date:  2014-01-28       Impact factor: 4.575

9.  Substance P promotes expansion of human mesenteric preadipocytes through proliferative and antiapoptotic pathways.

Authors:  Kara Gross; Iordanes Karagiannides; Thomas Thomou; Hon Wai Koon; Collin Bowe; Ho Kim; Nino Giorgadze; Tamara Tchkonia; Tamara Pirtskhalava; James L Kirkland; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-12       Impact factor: 4.052

Review 10.  Substance P, obesity, and gut inflammation.

Authors:  Iordanes Karagiannides; Charalabos Pothoulakis
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-02       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.